BHVN
Price:
$9.61
Market Cap:
$1.02B
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Industry
Biotechnology
IPO Date
2022-09-23
Stock Exchange
NYSE
Ticker
BHVN
According to Biohaven Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.86. This represents a change of -8.43% compared to the average of 3.13 of the last 4 quarters.
The mean historical Current Ratio of Biohaven Ltd. over the last ten years is 7.08. The current 2.86 Current Ratio has changed 3.94% with respect to the historical average. Over the past ten years (40 quarters), BHVN's Current Ratio was at its highest in in the June 2018 quarter at 17.84. The Current Ratio was at its lowest in in the December 2017 quarter at 0.
Average
7.08
Median
5.74
Minimum
2.26
Maximum
14.49
Discovering the peaks and valleys of Biohaven Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 188.36%
Maximum Annual Current Ratio = 14.49
Minimum Annual Increase = -64.42%
Minimum Annual Current Ratio = 2.26
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 3.49 | -56.26% |
| 2023 | 7.98 | 22.43% |
| 2022 | 6.52 | 188.36% |
| 2021 | 2.26 | -24.73% |
| 2020 | 3.00 | -39.44% |
| 2019 | 4.96 | -64.42% |
| 2018 | 13.94 | -3.81% |
The current Current Ratio of Biohaven Ltd. (BHVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.00
5-year avg
4.65
10-year avg
7.08
Biohaven Ltd.’s Current Ratio is less than Intellia Therapeutics, Inc. (6.21), less than Immunome, Inc. (12.13), less than AbCellera Biologics Inc. (10.10), less than Vera Therapeutics, Inc. (16.92), less than Zenas BioPharma, Inc. (5.23), less than Celldex Therapeutics, Inc. (19.67), less than Pharvaris N.V. (8.33), greater than Xeris Biopharma Holdings, Inc. (1.95), less than Sionna Therapeutics, Inc. (35.33), less than Immunocore Holdings plc (6.00),
| Company | Current Ratio | Market cap |
|---|---|---|
| 6.21 | $1.02B | |
| 12.13 | $1.84B | |
| 10.10 | $1.09B | |
| 16.92 | $2.72B | |
| 5.23 | $1.60B | |
| 19.67 | $1.97B | |
| 8.33 | $1.80B | |
| 1.95 | $1.12B | |
| 35.33 | $1.82B | |
| 6.00 | $2.03B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biohaven Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biohaven Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Biohaven Ltd.'s Current Ratio?
How is the Current Ratio calculated for Biohaven Ltd. (BHVN)?
What is the highest Current Ratio for Biohaven Ltd. (BHVN)?
What is the 3-year average Current Ratio for Biohaven Ltd. (BHVN)?
What is the 5-year average Current Ratio for Biohaven Ltd. (BHVN)?
How does the current Current Ratio for Biohaven Ltd. (BHVN) compare to its historical average?